ATE504002T1 - Erkennung und vorhersage von frühgeburten - Google Patents
Erkennung und vorhersage von frühgeburtenInfo
- Publication number
- ATE504002T1 ATE504002T1 AT07700392T AT07700392T ATE504002T1 AT E504002 T1 ATE504002 T1 AT E504002T1 AT 07700392 T AT07700392 T AT 07700392T AT 07700392 T AT07700392 T AT 07700392T AT E504002 T1 ATE504002 T1 AT E504002T1
- Authority
- AT
- Austria
- Prior art keywords
- prediction
- detection
- premature birth
- technology described
- predicting
- Prior art date
Links
- 208000005107 Premature Birth Diseases 0.000 title 1
- 206010036590 Premature baby Diseases 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 201000011461 pre-eclampsia Diseases 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Mold Materials And Core Materials (AREA)
- Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Holo Graphy (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0600916.1A GB0600916D0 (en) | 2006-01-17 | 2006-01-17 | detecting and predicting pre-eclampsia |
| PCT/GB2007/000123 WO2007083099A1 (en) | 2006-01-17 | 2007-01-17 | Detecting and predicting pre-eclampsia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE504002T1 true ATE504002T1 (de) | 2011-04-15 |
Family
ID=35998177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07700392T ATE504002T1 (de) | 2006-01-17 | 2007-01-17 | Erkennung und vorhersage von frühgeburten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7638287B2 (enExample) |
| EP (1) | EP1974220B1 (enExample) |
| JP (1) | JP2009524014A (enExample) |
| AT (1) | ATE504002T1 (enExample) |
| AU (1) | AU2007206756B2 (enExample) |
| CA (1) | CA2602681C (enExample) |
| DE (1) | DE602007013524D1 (enExample) |
| ES (1) | ES2364314T3 (enExample) |
| GB (1) | GB0600916D0 (enExample) |
| WO (1) | WO2007083099A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008098734A1 (en) | 2007-02-12 | 2008-08-21 | Stefan Hansson | Diagnosis and treatment of preeclampsia |
| GB0715030D0 (en) * | 2007-08-02 | 2007-09-12 | Wilson Carol J | Testing process |
| US8647832B2 (en) | 2008-01-25 | 2014-02-11 | Perkinelmer Health Sciences, Inc. | Methods for determining the risk of prenatal complications |
| CN102224422A (zh) * | 2008-11-20 | 2011-10-19 | 珀金埃尔默健康科学公司 | 使用pigf-2和pigf-3标志物确定先兆子痫风险的方法 |
| WO2010091253A1 (en) | 2009-02-06 | 2010-08-12 | Women & Infants' Hospital Of Rhode Island | Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy |
| AU2011231982B2 (en) * | 2010-03-24 | 2014-02-20 | Preelumina Diagnostics Ab | HbF and A1M as early stage markers for preeclampsia |
| WO2013087887A2 (en) * | 2011-12-15 | 2013-06-20 | Pronota N.V. | Biomarkers and parameters for hypertensive disorders of pregnancy |
| ES2718905T3 (es) * | 2012-04-24 | 2019-07-05 | Siemens Healthcare Diagnostics Inc | Métodos de examen de preeclampsia |
| WO2014124396A1 (en) * | 2013-02-08 | 2014-08-14 | University Of Iowa Research Foundation | Therapeutic strategies for the treatment of preeclampsia |
| US10119978B2 (en) * | 2013-03-15 | 2018-11-06 | Wallac Oy | System and method for determining risk of diabetes based on biochemical marker analysis |
| EP3189336B1 (en) | 2014-09-02 | 2018-11-07 | Wallac OY | Method for determining risk of pre-eclampsia |
| FR3037657B1 (fr) * | 2015-06-22 | 2017-06-23 | Univ Rouen Centre Hospitalier | Methode de diagnostic des troubles causes par l'alcoolisation foetale |
| US20200395127A1 (en) * | 2017-11-17 | 2020-12-17 | University Of Washington | Connected system for information-enhanced test results |
| EP4070113A4 (en) | 2019-12-04 | 2023-12-20 | Biora Therapeutics, Inc. | ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS |
| GB2620035A (en) * | 2021-02-10 | 2023-12-27 | Mirvie Inc | Methods and systems for conducting pregnancy-related clinical trials |
| FR3157091A1 (fr) * | 2023-12-26 | 2025-06-27 | Universite De Montpellier | Prédiction du comportement biomécanique de la paroi artérielle à travers l’analyse temporelle du signal oscillométrique au cours de la mesure de pression |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5331298A (en) | 1996-12-23 | 1998-07-17 | Cambridge University Technical Services Limited | Diagnosis and treatment of pathological pregnancies |
| GB0026823D0 (en) | 2000-11-02 | 2000-12-20 | King S College London | Diagnosis of pre-eclampsia |
| US7435419B2 (en) * | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
| GB0308967D0 (en) * | 2003-04-17 | 2003-05-28 | Univ London | Screen for pre-eclampsia |
| US7344892B2 (en) * | 2003-09-23 | 2008-03-18 | Beth Israel Deaconess Medical Center, Inc. | Screening for gestational disorders |
| CA2485722A1 (en) * | 2003-10-22 | 2005-04-22 | Paul Lehmann | Soluble transferrin receptor |
-
2006
- 2006-01-17 GB GBGB0600916.1A patent/GB0600916D0/en not_active Ceased
-
2007
- 2007-01-16 US US11/623,480 patent/US7638287B2/en not_active Expired - Fee Related
- 2007-01-17 WO PCT/GB2007/000123 patent/WO2007083099A1/en not_active Ceased
- 2007-01-17 AU AU2007206756A patent/AU2007206756B2/en active Active
- 2007-01-17 EP EP07700392A patent/EP1974220B1/en active Active
- 2007-01-17 CA CA2602681A patent/CA2602681C/en active Active
- 2007-01-17 DE DE602007013524T patent/DE602007013524D1/de active Active
- 2007-01-17 ES ES07700392T patent/ES2364314T3/es active Active
- 2007-01-17 AT AT07700392T patent/ATE504002T1/de not_active IP Right Cessation
- 2007-01-17 JP JP2008549934A patent/JP2009524014A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2364314T8 (es) | 2011-09-22 |
| CA2602681A1 (en) | 2007-07-26 |
| CA2602681C (en) | 2017-03-14 |
| AU2007206756A1 (en) | 2007-07-26 |
| US20070178530A1 (en) | 2007-08-02 |
| GB0600916D0 (en) | 2006-02-22 |
| AU2007206756B2 (en) | 2011-06-16 |
| EP1974220A1 (en) | 2008-10-01 |
| JP2009524014A (ja) | 2009-06-25 |
| EP1974220B1 (en) | 2011-03-30 |
| WO2007083099A1 (en) | 2007-07-26 |
| US7638287B2 (en) | 2009-12-29 |
| DE602007013524D1 (de) | 2011-05-12 |
| HK1119244A1 (en) | 2009-02-27 |
| ES2364314T3 (es) | 2011-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE504002T1 (de) | Erkennung und vorhersage von frühgeburten | |
| WO2009058902A3 (en) | Methods and devices for analyte detection | |
| NZ605698A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX2013001042A (es) | Biomarcadores de cancer pancreatico y usos de los mismos. | |
| MX2020004617A (es) | Prediccion de riesgo de evento cardiovascular y usos del mismo. | |
| WO2008019375A3 (en) | Proteomic patterns of cancer prognostic and predictive signatures | |
| NZ602056A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2008021290A3 (en) | Organ-specific proteins and methods of their use | |
| DK2885641T3 (da) | Fremgangsmådeer til forudsigelse af risiko for udvikling af hypertension | |
| WO2014065889A3 (en) | Multiplexed method for diagnosing classical hodgkin lymphoma | |
| WO2008060394A3 (en) | Methods and assays for detecting gp73-specific autoantibodies | |
| NZ609824A (en) | Immunochromatography devices, methods and kits | |
| NZ608316A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| TW200720441A (en) | New labelling strategies for the sensitive detection of analytes | |
| TW200745551A (en) | Device and methods for detecting and quantifying one or more target agents | |
| WO2011142781A3 (en) | Pore-limit electrophoresis (ple) microchannel assays | |
| MY145455A (en) | Diagnostic biomolecule(s) | |
| DK2118666T3 (da) | Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve | |
| WO2008124091A3 (en) | Compositions and methods of detection | |
| DE602007012836D1 (de) | Cd86- und cd80-rezeptorkonkurrenztests | |
| NZ601648A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX2009008525A (es) | La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms. | |
| WO2011113813A3 (en) | Assay for analytes based on aggregation | |
| NZ605561A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2006099537A3 (en) | The use of antibody-surrogate antigen systems for detection of analytes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |